Letter from the Executive Chairman
Welcome to the investor relations section of the Advanced Oncotherapy website.
Advanced Oncotherapy's sole focus is to develop technology to maximise the destructive effect of irradiating cancerous tumours, while keeping surrounding tissue healthy. Our goal is to provide cancer centres/hospitals with the flexibility to expand their repertoire of cancer treatment options. Advanced Oncotherapy aims to deliver the next generation of radiotherapy system, using proton beams, to be both cost effective and clinically superior to alternative machines currently available.
The team, led by me as Executive Chairman and our CEO, Nicolas Serandour, with the active support from the Board and our expert advisers, is currently focussed on the delivery and installation of our first LIGHT system, with construction at Harley Street commencing in early 2017.
The Board places great importance on establishing and maintaining effective communication with investors and the media. Our investor and news sections will ensure that you - as existing or potential shareholders - can track our progress and obtain news and updates as soon as they become available. And, if you prefer using social media, follow us on Twitter @AdvOnco_AVO or on Facebook.
Mike Sinclair, Executive Chairman